Patents-Review.com
ClassID:

21462 ⎘

A61K49/0433 - CPC Classification

Classification description:

Preparations for testing; X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent

Sub-classes:
Recent Application in this class:
#1
20220105246
2022-04-07

COMPOSITIONS AND METHODS FOR TREATING THE VERTEBRAL COLUMN

 #2
20210236660
2021-08-05

IMAGEABLE POLYMERS

 #3
20210236659
2021-08-05

Methods and devices to generate [F-18]triflyl fluoride and other [F-18] sulfonyl fluorides

 #4
20200353103
2020-11-12

Contrast imaging agent with dissolved gas-evolving fluid

 #5
20200254117
2020-08-13

Imageable polymers

 #6
20200015766
2020-01-16

Bolus imaging

 #7
20190111159
2019-04-18

Imageable polymers

 #8
20180257939
2018-09-13

Setting of hardenable bone substitute

 #9
20180168529
2018-06-21

Bolus imaging

 #10
20180161463
2018-06-14

Diagnostic imaging agent for early bone metastasis from cancer

 #11
20180022719
2018-01-25

Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors

 #12
20160376298
2016-12-29

Prototype systems of theranostic biomarkers for in vivo molecular management of cancer

 #13
20160194266
2016-07-07

Pharmaceutical compound for the prevention and treatment

 #14
20160193367
2016-07-07

Imageable polymers

 #15
20160137629
2016-05-19

Compounds for binding to the platelet specific glycoprotein IIb/IIIa and their use for imaging of thrombi

 #16
20160058822
2016-03-03

Radiopaque injectable nucleus hydrogel compositions

 #17
20160015856
2016-01-21

Setting of hardenable bone substitute

 #18
20160000972
2016-01-07

Compositions and methods for treating the vertebral column

 #19
20150374883
2015-12-31

Bone graft substitute containing a temporary contrast agent and a method of generating such and a method of use thereof

 #20
20150297756
2015-10-22

Protein-based nanobubble x-ray imaging method and agent

 #21
20150191422
2015-07-09

Contrast agents

 #22
20150190533
2015-07-09

X-ray imaging contrast media with low iodine concentration and X-ray imaging process

 #23
20150133777
2015-05-14

Positron emission tomography probe to monitor selected sugar metabolism in vivo

 #24
20150132223
2015-05-14

Catalytic radiofluorination

 #25
20150110722
2015-04-23

Imageable polymers

 #26
20140341812
2014-11-20

BETA-AMYLOID PET IMAGING AGENTS

 #27
20140227194
2014-08-14

Preparation for Restenosis Prevention

 #28
20140227193
2014-08-14

Preparation for Restenosis Prevention

 #29
20140227192
2014-08-14

Preparation for Restenosis Prevention

 #30
20140154183
2014-06-05

[F-18]-labelled L-glutamic acid and L-glutamine derivatives (I), their use and processes for their preparation

 #31
20130115168
2013-05-09

Catalytic radiofluorination

 #32
20130004433
2013-01-03

Preparation of stabilised x-ray diagnostic composition

 #33
20120207677
2012-08-16

Catalytic radiofluorination

 #34
20120134933
2012-05-31

USE OF HIGH-DOSES OF MONOMERIC CONTRAST MEDIUM CONTAINING IODINE IN X-RAY DIAGNOSTICS, IN PARTICULAR IN INTERVENTIONAL X-RAY DIAGNOSTICS AND IN RADIATION THERAPY ASSISTED BY CONTRAST MEDIA CONTAINING IODINE

 #35
20120128588
2012-05-24

Isotope labeled 2-arylpropionic acid compounds and process for production of same, and molecular probe for positron emission tomography and method for imaging of cyclooxygenase and the like using same

 #36
20110200695
2011-08-18

GEL COMPOSITION FOR FILLING A BREAST MILK DUCT PRIOR TO SURGICAL EXCISION OF THE DUCT OR OTHER BREAST TISSUE

 #37
20110165076
2011-07-07

NOVEL [F-18]- LABELLED L-GLUTAMIC ACID AND L-GLUTAMINE DERIVATIVES (I), USE THEREOF AND METHOD FOR THEIR PRODUCTION

 #38
20110097376
2011-04-28

Radiopaque injectable nucleus hydrogel compositions

 #39
20110097280
2011-04-28

Intracorporeal Medicaments for Photodynamic Treatment of Disease

 #40
20110065959
2011-03-17

Removal of silica from water soluble compounds by nanofiltration and reverse phase chromatography

 #41
20110008255
2011-01-13

Beta-amyloid PET imaging agents

 #42
20100322868
2010-12-23

Contrast agents

 #43
20100290991
2010-11-18

NOVEL [F-18]-LABELLED L-GLUTAMIC ACID AND L-GLUTAMINE DERIVATIVES (I), THEIR USE AND PROCESSES FOR THEIR PREPARATION

 #44
20100278997
2010-11-04

Preparation for restenosis prevention

 #45
20100278744
2010-11-04

Preparation for restenosis prevention

 #46
20100233097
2010-09-16

Contrast agents

 #47
20100233086
2010-09-16

COMPOUNDS FOR USE IN IMAGING, DIAGNOSING AND/OR TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM OR OF TUMORS

 #48
20100209356
2010-08-19

CONTRAST AGENTS

 #49
20100209347
2010-08-19

Cyclodextrin compound modified with folic acid, process for production thereof, drug delivery agent for targeting drug delivery system, pharmaceutical composition, and imaging agent

 #50
20100189656
2010-07-29

CONTRAST AGENTS

 #51
20100183522
2010-07-22

CONTRAST AGENTS

 #52
20100183515
2010-07-22

Compositions and methods for treating the vertebral column

 #53
20100028258
2010-02-04

Radioactive diagnostic imaging agent

 #54
20090280055
2009-11-12

Use of Fluorine-Containing Compounds for Diagnostic Purposes Using Imaging Methods

 #55
20090266995
2009-10-29

X-ray attenuating compositions and methods

 #56
20090252678
2009-10-08

COX-2-TARGETED IMAGING AGENTS

 #57
20090203877
2009-08-13

X-RAY-DENSE CONJUGATE

 #58
20090191129
2009-07-30

Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors

 #59
20090136425
2009-05-28

Contrast agents

 #60
20090053142
2009-02-26

Contrast agents

 #61
20080207746
2008-08-28

Intracorporeal medicaments for photodynamic treatment of disease

 #62
20080199404
2008-08-21

Contrast agents

 #63
20080199402
2008-08-21

Contrast agents

 #64
20080159954
2008-07-03

Metal chelates having a perfluorinated PEG radical, processes for their preparation, and their use

 #65
20080102034
2008-05-01

PREPARATION FOR THE PROPHYLAXIS OF RESTENOSIS

 #66
20080102033
2008-05-01

PREPARATION FOR THE PROPHYLAXIS OF RESTENOSIS

 #67
20070264201
2007-11-15

Contrast agents

 #68
20070202048
2007-08-30

Implants comprising an osteoinductive factor and a contrast agent compatible therewith

 #69
20070196277
2007-08-23

Compositions and Methods for the Direct Therapy of Tumors

 #70
20070189968
2007-08-16

Gel composition for filling a breast milk duct prior to surgical excision of the duct or other breast tissue

 #71
20070148096
2007-06-28

Contrast Agents

 #72
20070128120
2007-06-07

Organic radiographic contrasting agents for medical devices

 #73
20070088087
2007-04-19

Concentrated X-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions

 #74
20070078076
2007-04-05

Intracorporeal medicaments for high energy phototherapeutic treatment of disease

 #75
20070010575
2007-01-11

Intracorporeal medicaments for photodynamic treatment of disease

 #76
20060199859
2006-09-07

Topical medicaments and methods for photodynamic treatment of disease

 #77
20060002858
2006-01-05

Concentrated X-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions

 #78
20050282889
2005-12-22

Intracorporeal medicaments for photodynamic treatment of disease

 #79
20050250672
2005-11-10

Preparation for the prophylaxis of restenosis

 #80
20050207976
2005-09-22

High energy phototherapeutic agents

 #81
20050154049
2005-07-14

Intracorporeal medicaments for photodynamic treatment of disease

 #82
20050136001
2005-06-23

Fluorinated carbohydrate conjugates

 #83
20050119746
2005-06-02

Bioresorbable bone mineral substitute comprising water-soluble X-ray contrast agent

 #84
20050101522
2005-05-12

Preparation for the prophylaxis of restenosis

 #85
20050025711
2005-02-03

Contrast media formulations having improved biological tolerance

 #86
20050002864
2005-01-06

1,3-glyceride compound having two iodophenyl groups

 #87
20050002859
2005-01-06

COX-2-targeted imaging agents